User 19 ran 500mcg twice daily for 13 weeks across a chronic multi-injury case involving a 10-year back injury and a 4-year shoulder injury, adding GHK-Cu, ipamorelin, and CJC-1295 to the protocol, and reported 90 percent pain relief after one cycle
longer at -20C per supplier label
Rituximab (Rituxan, Truxima) Rituximab (Rituxan) and biosimilar rituximab-abbs (Truxima) are biologic agents that deplete B cells (cells that produce antibodies) by binding to CD20+, a protein on the surface of certain B cells
While both peptides have been studied for tissue-regenerative properties, they appear to function through different mechanisms: BPC-157 may work primarily through growth factor-mediated pathways and nitric oxide systems
However, more human clinical trials are still needed
That matters because, unlike most peptides, a small molecule can be studied orally as well as by injection it has no peptide bonds for digestive enzymes to cleave